The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19

NCT ID: NCT04871685

Last Updated: 2021-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

950 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-18

Study Completion Date

2021-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed analyzing chest posterior and lateral spaces, considering the number of artefacts generated by the inflammed interstitium (B lines), the characteristics of the pleural line and the presence or not of consolidation areas.

The comparison between LUS and chest tomography (CT), the current gold standard for the diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the reliability of such technique. Hence, the validation on a really large sample size of the ultrasound tool performed by dedicated personnel with high expertise, may allow the validation both in the clinical practice and in emergency and ordinary wards.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Covid Center UOC Vanvitelli, Naples

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Cotugno Hospital, Naples

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center "Del Mare Hospital", Naples

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Santa Maria delle Grazie Hospital, Pozzuoli

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Monaldi Hospital, Naples

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Vannini Hospital, Rome

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Bassini Hospital, ASST Milano Nord

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Melfi Hospital

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Covid Center Messina University Hospital

Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units

lung ultrasound

Intervention Type DIAGNOSTIC_TEST

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lung ultrasound

the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men and women;
* confirmed COVID19 diagnosis after nasal-oropharyngeal swab;
* any symptom at hospitalization
* any therapy
* any pre-existing comorbidity

Exclusion Criteria

* pregnant women
* healthy subjects with other respiratory diseases different from COVID-19
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Campania Luigi Vanvitelli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luca Rinaldi

Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Campania Luigi Vanvitelli

Naples, Campania, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Vanvitelli

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effort-Lung Ultra Sound
NCT04644692 COMPLETED